Andrew Chang 1, Garrett W Easson 1, Simon Y Tang 1 2 3 Clin Rev Bone Miner Metab. 2018 Sep;16(3):87-94. doi: 10.1007/s12018-018-9249-9. Epub 2018 Sep 12. PMID: 30983912 PMCID: PMC6457660 DOI: 10.1007/s12018-018-9249-9 Over […]
Sabina Herrera 1, Adolfo Diez-Perez 2 Bone. 2017 Feb;95:175-182. DOI: 10.1016/j.bone.2016.11.003. Epub 2016 Nov 11. PMID: 27840302 DOI: 10.1016/j.bone.2016.11.003 Densitometry and imaging techniques are currently
John P. Bilezikian (Editor-in-Chief) ISBN: 978-1-119-26656-3 November 2018 Wiley-Blackwell 1136 Pages The authoritative reference to bone diseases and disorders of mineral metabolism, revised and
Manuela Schoeb 1, Neveen A T Hamdy 1, Frank Malgo 1, Elizabeth M Winter 1, Natasha M Appelman-Dijkstra 1 Front Endocrinol (Lausanne). 2020 Feb 7;11:15. doi: 10.3389/fendo.2020.00015. eCollection 2020. PMID: 32117052PMCID: PMC7020781 DOI: 10.3389/fendo.2020.00015 The
Donald H Lee 1, Kaitlyn Reasoner 2, Sasidhar Uppuganti 1, Mihir J Desai 1, Jeffry S Nyman 1PMID: 35778010DOI: 10.1063/5.0082751 Impact microindentation is a new technique that measures the resistance
Donald H Lee 1, Kaitlyn Reasoner 2, Sasidhar Uppuganti 1, Mihir J Desai 1, Jeffry S Nyman 1PMID: 35778010DOI: 10.1063/5.0082751 Impact microindentation is a new technique that measures the resistance
Manuela Schoeb 1, Neveen A T Hamdy 1, Frank Malgo 1, Elizabeth M Winter 1, Natasha M Appelman-Dijkstra 1 Front Endocrinol (Lausanne). 2020 Feb 7;11:15. doi: 10.3389/fendo.2020.00015. eCollection 2020. PMID: 32117052 PMCID: PMC7020781 DOI: 10.3389/fendo.2020.00015
John P. Bilezikian (Editor-in-Chief) ISBN: 978-1-119-26656-3 November 2018 Wiley-Blackwell 1136 Pages The authoritative reference to bone diseases and disorders of mineral metabolism, revised and
Sabina Herrera 1, Adolfo Diez-Perez 2 Bone. 2017 Feb;95:175-182. DOI: 10.1016/j.bone.2016.11.003. Epub 2016 Nov 11. PMID: 27840302 DOI: 10.1016/j.bone.2016.11.003 Densitometry and imaging techniques are currently
Andrew Chang 1, Garrett W Easson 1, Simon Y Tang 1 2 3 Clin Rev Bone Miner Metab. 2018 Sep;16(3):87-94. doi: 10.1007/s12018-018-9249-9. Epub 2018 Sep 12. PMID: 30983912 PMCID: PMC6457660 DOI: 10.1007/s12018-018-9249-9 Over
Indication For Use and Safety Information
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
Like with any percutaneous procedure, there is a small risk of infection. The sale, distribution, and use of the OsteoProbe are restricted to prescription use. Federal law (United States of America) restricts this device to use by, or on the order of, a physician.
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy